Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid
REDWOOD CITY, Calif., June 12, 2025 /PRNewswire/ -- Synthego, a pioneering CRISPR Solutions provider, is pleased to announce that the US Court of Appeals for the Federal Circuit has upheld an earlier ruling invalidating patents held by Agilent Technologies, Inc. See the ruling here.
In the original case, ruling dated May 17, 2023, the Patent Trial and Appeal Board (PTAB) ruled in favor of Synthego's petitions seeking to invalidate Agilent's US Patents Nos. 10,337,001 (the '001 patent) and 10,900,034 (the '034 patent) in the Inter Partes Review before the PTAB.
The PTAB's original decision invalidated all claims of the Agilent patents, which were directed to guide RNAs having at least one 2'-O-methyl modification ('034 patent) and guide RNAs having certain modifications within 5 nucleotides of their 5' and/or 3' end ('001) patent), as well as methods of using such modified guide RNAs for CRISPR gene editing.
'This critical decision, affirming that Agilent's claims on chemically modified gRNAs are unpatentable, keeps the path clear for broader innovation and advancement in the CRISPR therapeutics market,' said Craig Christianson, CEO of Synthego. 'Synthego will continue our focus on supporting our clients' efforts to enhance human health with curative cell and gene therapies.'
Synthego continues to support innovation in the field of CRISPR-enabled research and therapeutics, this affirmation enables researchers and therapeutic developers to continue to drive successful patient outcomes.
About Synthego
Synthego is a leader in biotechnology, dedicated to delivering best-in-class CRISPR solutions with a mission to accelerate research and development in the pursuit of improved human health. By providing unparalleled access to CRISPR solutions at scale, Synthego enables agility in life science discovery and clinical advancement. With streamlined licensing models and exceptional technical expertise, Synthego empowers researchers and developers to unlock better patient outcomes through innovative CRISPR cell and gene therapies.
View original content to download multimedia: https://www.prnewswire.com/news-releases/synthego-prevails-in-patent-appeal-confirming-agilent-crispr-patents-are-invalid-302479683.html
SOURCE Synthego
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
GM to invest US$4 billion to increase US output
General Motors (GM) announced it plans to invest around US$ 4 billion in the next two years to strengthen its US vehicle production operations, in response to the recent import tariff hikes by the Trump-led US government. This new investment plan, which will result in the transfer of some production from Mexico, is in addition to the recently-announced US$ 888 million investment in the company's Tonawanda engine plant in New York State. GM confirmed it plans to increase its annual production capacity in the US to over two million battery-powered and internal combustion engine (ICE) vehicles. The plants that will benefit from the new investment include: Orion, Michigan, which will begin production of a ICE full-size SUVs and light duty pickup trucks in early 2027. The Detroit-Hamtramck plant will become the dedicated assembly location for the Chevrolet Silverado EV, GMC Sierra EV, Cadillac Escalade IQ, and GMC Hummer EV pickup and SUV. Fairfax, Kansas City, will produce ICE-powered Chevrolet Equinox from mid-2027 in response to strong demand for the recently redesigned model. The plant is also scheduled to produce the new Chevrolet Bolt EV by the end of 2025, with additional 'affordable' EV models set to follow later on. Spring Hill, Tennessee: GM plans to add the ICE-powered Chevrolet Blazer to the plant's line-up from 2027, to be produced alongside the Cadillac Lyriq and Visiq EVs and the Cadillac XT5. GM's CEO, Mary Barra, said in a statement: 'We believe the future of transportation will be driven by American innovation and manufacturing expertise. Today's announcement demonstrates our ongoing commitment to build vehicles in the US and to support American jobs. We're focused on giving customers choice and offering a broad range of vehicles they love.' The company pointed out that it currently has around fifty vehicle and parts manufacturing plants in 19 US states, including eleven vehicle assembly plants, employing a COMBINED one million people directly and indirectly, including at parts suppliers and dealers. GM's capital spending guidance remained unchanged at between US$ 10 billion and US$ 11 billion for 2025, rising slightly to between US$ 10 billion and US$ 12 billion in 2026 and 2027 to 'reflect increased investment in the US, the prioritization of key programs, and efficiency offsets.' "GM to invest US$4 billion to increase US output" was originally created and published by Just Auto, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Business Insider
an hour ago
- Business Insider
Meta, OpenAI, and Palantir (PLTR) Executives Join U.S. Army to Improve Military Tech
Top tech leaders from Meta (META), OpenAI, and Palantir (PLTR) are joining the Army Reserve as lieutenant colonels in a new unit called the 'Executive Innovation Corps,' known as Detachment 201, the Army announced Friday. The unit is part of a push to bring Silicon Valley expertise into the military. Among those being sworn in are Meta CTO Andrew Bosworth, OpenAI Chief Product Officer Kevin Weil, Palantir CTO Shyam Sankar, and Bob McGrew, an advisor at Thinking Machines and former OpenAI Chief Research Officer. Confident Investing Starts Here: Detachment 201 will let these tech leaders serve part-time as senior advisors in order to help the Army adopt advanced technologies quickly. The unit is designed to fuse cutting-edge commercial tech with military innovation, which will support projects like the Army Transformation Initiative that aims to modernize the force by using more efficient and scalable solutions. The program also allows executives to serve without leaving their day jobs, which could inspire more tech professionals to contribute in uniform. This initiative comes as the Army works to replace outdated systems and buy more commercial tech that can serve both military and civilian needs. Indeed, Meta is already partnering with defense firm Anduril on extended reality (XR) tools for soldiers. In addition, OpenAI's ChatGPT could be used to improve military productivity, while Palantir supplies AI-enabled hardware like the TITAN vehicle. The Army didn't say how fast Detachment 201 will expand, but this first wave of new members points to a growing collaboration between the tech industry and the military. Which Tech Stock Is the Better Buy?
Business Upturn
2 hours ago
- Business Upturn
Bombardier Completes Partial Redemption of US$500,000,000 of its 7.875% Senior Notes due 2027
By GlobeNewswire Published on June 14, 2025, 02:01 IST MONTRÉAL, June 13, 2025 (GLOBE NEWSWIRE) — Bombardier Inc. ('Bombardier') today announced that it has redeemed US$500 million principal amount of its outstanding 7.875% Senior Notes due 2027 (the 'Redemption Notes') as set forth in the notice of partial redemption issued May 14, 2025. Payment of the redemption price and surrender of the Redemption Notes for redemption are being made through the facilities of the Depository Trust Company in accordance with the applicable procedures of the Depository Trust Company. This press release does not constitute an offer to sell or buy or the solicitation of an offer to buy or sell any security and shall not constitute an offer, solicitation, sale or purchase of any securities in any jurisdiction in which such offering, solicitation, sale or purchase would be unlawful. The Redemption Notes mentioned herein have not been and will not be registered under the United States Securities Act of 1933, as amended, any state securities laws or the laws of any other jurisdiction, and may not be offered or sold in the United States absent registration or an applicable exemption from such registration requirements. The Redemption Notes mentioned herein have not been and will not be qualified for distribution to the public under applicable Canadian securities laws and, accordingly, any offer and sale of the securities in Canada may only be made on a basis which is exempt from the prospectus requirements of such securities laws. FORWARD-LOOKING STATEMENTS Certain statements in this announcement are forward-looking statements based on current expectations. By their nature, forward-looking statements require us to make assumptions and are subject to important known and unknown risks and uncertainties, which may cause our actual results in future periods to differ materially from those set forth in the forward-looking statements. For information Francis Richer de La FlècheVice President, Financial Planning and Investor RelationsBombardier +1 514 240 9649 Mark MasluchSenior Director, CommunicationsBombardier +1 514 855 7167 Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
